association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a75 |
gain_cnaPANCAN364_(STK4) |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
58 |
734 |
2.3 |
1.5 |
2.24 |
0.745 |
0.59 . |
0.6 . |
0.51 . |
3.2e-06 |
9.63e-09 |
4.34e-02 |
0.7 |
a224 |
loss_cnaPANCAN227, loss_cnaPANCAN228 |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
24 |
768 |
2.3 |
1.52 |
2.53 |
1 |
0.79 . |
0.79 . |
0.82 . |
1.17e-04 |
1.27e-08 |
4.43e-02 |
8.6 |
a305 |
loss_cnaPANCAN229 |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
26 |
766 |
2.3 |
1.52 |
2.48 |
0.965 |
0.76 . |
0.76 . |
0.77 . |
2.57e-04 |
1.35e-08 |
4.45e-02 |
14 |
a341 |
gain_cnaPANCAN366 |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
69 |
723 |
2.3 |
1.5 |
2.07 |
0.565 |
0.45 |
0.45 |
0.39 |
3.17e-04 |
1.37e-08 |
4.46e-02 |
15 |
a386 |
gain_cnaPANCAN363_(ASXL1) |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
82 |
710 |
2.3 |
1.5 |
2.02 |
0.523 |
0.41 |
0.42 |
0.38 |
4.14e-04 |
1.4e-08 |
4.47e-02 |
18 |
a465 |
loss_cnaPANCAN162 |
1239 |
1 |
1 |
YK 4-279 |
RNA helicase A |
20 |
772 |
2.3 |
1.53 |
2.41 |
0.876 |
0.69 . |
0.69 . |
0.58 . |
6.04e-04 |
1.44e-08 |
4.48e-02 |
21 |